美国最高法院驳回了普渡制药公司涉及萨克勒家族的 60 亿美元阿片类药物危机和解协议。 The US Supreme Court rejected Purdue Pharma's $6bn opioid crisis settlement deal involving the Sackler family.
美国最高法院拒绝了奥施康定生产商普渡制药与其所有者萨克勒家族达成的和解协议。 The US Supreme Court denied a settlement deal for Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family. 这笔价值 60 亿美元的交易将使普渡转变为一家公益公司，其利润将用于抗击阿片类药物危机，而萨克勒家族将贡献高达 60 亿美元。 The $6 billion deal would have seen Purdue converted into a public benefits corporation, with profits used to fight the opioid crisis and the Sacklers contributing up to $6 billion.